Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ionic Bonds00:42

Ionic Bonds

When atoms gain or lose electrons to achieve a more stable electron configuration they form ions. Ionic bonds are electrostatic attractions between ions with opposite charges. Ionic compounds are rigid and brittle when solid and may dissociate into their constituent ions in water. Covalent compounds, by contrast, remain intact unless a chemical reaction breaks them.Opposing Charges Hold Ions Together in Ionic CompoundsIonic bonds are reversible electrostatic interactions between ions with...
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemostatic Response to Palliative Radiotherapy for Bleeding Gastric Cancer and Pretreatment Endoscopic Characteristics: A Retrospective Cohort Study.

Internal medicine (Tokyo, Japan)·2026
Same author

Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.

Annals of gastroenterological surgery·2026
Same author

Endoscopic Submucosal Dissection versus Endoscopic Papillectomy for Ampullary Tumors with a Lesion Base ≥20 mm: A Single-Center Retrospective Comparative Study.

Gastrointestinal endoscopy·2026
Same author

Electrophilic monocarbonyl curcumin derivatives reveal differential vulnerabilities in the selenium metabolic network.

Free radical biology & medicine·2026
Same author

Nrf2 activation by the monocarbonyl curcumin derivative GO-Y015 confers cellular protection against arsenite toxicity by reducing intracellular arsenic levels.

Scientific reports·2026
Same author

Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world study.

Journal of gastroenterology·2026

Related Experiment Video

Updated: Jun 12, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

[Cancer and electrolytes imbalance].

Hiroyuki Shibata1

  • 1Department of Clinical Oncology, Graduate School of Medicine, Akita University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 23, 2010
PubMed
Summary

Electrolyte imbalances like hyperkalemia, hypercalcemia, and hyponatremia are common in advanced cancer patients. Prompt treatment can improve or cure these serious conditions, including new-onset hypomagnesemia from targeted cancer therapies.

Area of Science:

  • Oncology
  • Endocrinology
  • Nephrology

Context:

  • Advanced cancer patients frequently experience electrolyte imbalances.
  • These imbalances, including hyperkalemia, hypercalcemia, and hyponatremia, arise from various factors like chemotherapy, paraneoplastic syndromes, and osteolysis.
  • Newer targeted therapies, such as epidermal growth factor receptor inhibitors, monoclonal antibodies, mTOR inhibitors, and ABL kinase inhibitors, introduce risks of hypomagnesemia and hypophosphatemia.

Purpose:

  • To review the causes and clinical significance of electrolyte imbalances in advanced cancer.
  • To highlight the emerging issue of hypomagnesemia and hypophosphatemia associated with novel cancer treatments.
  • To emphasize the importance of monitoring magnesium and phosphate levels.

Summary:

More Related Videos

Establishment of an Extracellular Acidic pH Culture System
09:41

Establishment of an Extracellular Acidic pH Culture System

Published on: November 19, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Establishment of an Extracellular Acidic pH Culture System
09:41

Establishment of an Extracellular Acidic pH Culture System

Published on: November 19, 2017

  • Electrolyte disturbances such as hyperkalemia, hypercalcemia, and hyponatremia are prevalent in advanced cancer, often linked to tumor lysis syndrome or paraneoplastic syndromes.
  • Hypercalcemia can stem from osteolysis or hormonal factors (e.g., parathyroid hormone-related protein), while hyponatremia may be caused by antidiuretic hormone-producing tumors.
  • Emerging targeted therapies are associated with hypomagnesemia and hypophosphatemia, necessitating careful monitoring of these electrolytes.
  • Impact:

    • Recognizing and promptly treating electrolyte imbalances can prevent severe complications like encephalopathy and arrhythmia.
    • Awareness of treatment-induced electrolyte disturbances is crucial for managing patients on modern oncological therapies.
    • Close monitoring of serum magnesium and phosphate levels is essential for optimizing patient care and outcomes in the era of targeted cancer treatments.